Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers

Emily Vogtmann, Douglas A Corley, Lucy M Almers, Chris R. Cardwell, Liam J Murray, Christian C Abnet

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
132 Downloads (Pure)

Abstract

The association between oral bisphosphonate use and upper gastrointestinal cancer has been controversial. Therefore, we examined the association with esophageal and gastric cancer within the Kaiser Permanente, Northern California population. A total of 1,011 cases of esophageal (squamous cell carcinoma and adenocarcinoma) and 1,923 cases of gastric adenocarcinoma (cardia, non-cardia and other) diagnosed between 1997 and 2011 from the Kaiser Permanente, Northern California cancer registry were matched to 49,886 and 93,747 controls, respectively. Oral bisphosphonate prescription fills at least one year prior to the index date were extracted. Conditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (95% CI) for the associations between prospectively evaluated oral bisphosphonate use with incident esophageal and gastric cancer diagnoses with adjustment for potential confounders. After adjustment for potential confounders, no significant associations were found for esophageal squamous cell carcinoma (OR 0.88; 95% CI: 0.51, 1.52), esophageal adenocarcinoma (OR 0.68; 95% CI: 0.37, 1.24), or gastric non-cardia adenocarcinoma (OR 0.83, 95% CI: 0.59, 1.18), but we observed an adverse association with gastric cardia adenocarcinoma (OR 1.64; 95% CI: 1.07, 2.50). In conclusion, we observed no association between oral bisphosphonate use and esophageal cancer risk within a large community-based population. A significant association was detected with gastric cardia and other adenocarcinoma risk, although this needs to be replicated.

Original languageEnglish
Pages (from-to)e0140180
JournalPloS one
Volume10
Issue number10
DOIs
Publication statusPublished - 07 Oct 2015

Fingerprint Dive into the research topics of 'Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers'. Together they form a unique fingerprint.

Cite this